A targeted approach to treating osteoarthritis

A targeted approach to treating osteoarthritis

Nanocarriers are tiny substances that can be used to transport other materials, such as drugs, to specific areas of the body. The EU-funded TARGETCARE project plans to use them to treat joint and intervertebral disc diseases - improving patients' mobility and quality of life.
Date: 
22/12/2016 - 13:14

An individual’s mobility can be seriously impaired by chronic low back pain and osteoarthritis caused by the degeneration of cartilage in intervertebral discs and joints. Osteoarthritis is the most common form of arthritis, affecting millions of people worldwide.

Read more

TargetCaRe
See also: 
Project details
Project: 
Targeting Cartilage Regeneration in joint and intervertebral disc diseases
Image of xray scan of body
© psdesign1 - fotolia.com
Rapid Press Release: 
Do Not Publish as Rapid Press Release
Contact
Source: 
http://ec.europa.eu/programmes/horizon2020/en/news/targeted-approach-treating-osteoarthritis

Share this post

Author